For decades, American waistlines have been expanding and there is increasing cause for alarm. Researchers make the case that metabolic syndrome is the new “silent killer,” analogous to hypertension in the 1970s. As it turns out, the “love handle” can be fatal.
From human behavior such as mother/infant bonding, addiction and communication disorders to devastating brain diseases like Parkinson’s and Alzheimer’s disease, neuroscientists and other researchers from FAU’s Brain Institute are at the forefront of innovative research that will generate knowledge to benefit society.
Although most children use their smartphones and social media apps in appropriate ways, about 25 percent will experience online bullying at some point.
Human voice pitch has been shown to influence how voters perceive candidates for elected office and appears to influence voters both in the laboratory and in real life as they tend to support candidates with lower-pitched voices. The remaining question is, how does this work?
An El Niño winter which brought record rainfall in January has been threatening the ecological health of the St. Lucie River in southeast Florida. Ongoing discharges from Lake Okeechobee are damaging the delicate balance of freshwater and saltwater in surrounding estuaries.
A boycott of Sunday night’s Academy Awards to protest the lack of racial diversity among the nominees is unlikely to create the change many hoped for, says a Florida Atlantic University professor who has studied boycotts for almost 20 years.
More than five million Americans and 15 million caregivers are impacted by Alzheimer's disease. A leading neuroscientist at Florida Atlantic University has developed eight myths and truths about this prevalent form of dementia.
Every 67 seconds someone is the United States develops Alzheimer’s disease or some form of dementia. James E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country, is at the helm of cutting-edge research, screening methods and clinical care for all forms of dementia and cognitive impairments as well as neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease.
Dr. Charles H. Hennekens has done ground-breaking research on the benefits of statins, aspirin, ACE inhibitors, ARBs as well as beta adrenergic blockers. His guidance will assist clinicians to address the clinical and public health challenges to increase utilization of statins in the treatment and prevention of heart attacks and strokes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right